Ketoprofen
Indications
Registered South African indications:
- Pain
- Inflammation
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- The third trimester of pregnancy
- Severe renal impairment
- Severe hepatic impairment
- History of hypersensitivity reactions such as bronchospasm, asthmatic attacks, rhinitis, angioedema, urticaria or other allergic-type reactions to ketoprofen, any other ingredients in this medicine, acetylsalicylic acid or other non-steroidal anti-inflammatory drugs. Severe, rarely fatal, anaphylactic reactions have been reported in such patients
- Severe heart failure
- Active peptic ulcer or any history of gastrointestinal bleeding, ulceration or perforation
- Haemorrhagic diathesis
Cautions
- Pregnancy <30 weeks
- Breastfeeding
- Mild to moderate renal impairment
- Mild to moderate hepatic impairment
- Elderly
- History of hypertension
- Mild to moderate congestive heart failure
- Ischaemic heart disease
- Peripheral arterial disease
- Cerebrovascular disease
- Respiratory disorders
- Gastrointestinal bleeding, ulceration and perforation
- Systemic lupus erythematosus and mixed connective tissue disease
- Dehydration
Adult dosage
Forms avail. in SA in this monograph: ER cap
Rheumatoid arthritis
Osteoarthritis
- Oral (ER cap): 200mg, dly
Take with food or milk
Ketoflam (sustained-release capsules) is not intended for initial therapy
Paediatric dosage
Not established for use in children
Special populations
Pregnancy
- First and second trimester: Caution
- Third trimester: Contraindicated
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Central Nervous System Disorders
- Headache
- Dizziness
- Somnolence
- Paraesthesia
- Convulsions
- Dysgeusia
- Depression
- Confusion
- Hallucinations
- Vertigo
- Malaise
- Drowsiness
- Aseptic meningitis
Cardiovascular Disorders
- Heart failure
- Oedema
- Hypertension
- Vasodilatation
Respiratory Disorders
- Asthma
- Bronchospasm
- Rhinitis
- Non-specific allergic reactions
- Dyspnoea
Gastrointestinal Disorders
- Dyspepsia
- Nausea and vomiting
- Abdominal pain
- Constipation
- Diarrhoea
- Flatulence
- Gastritis
- Stomatitis
- Peptic ulcer
- Pancreatitis
- Exacerbation of colitis and Crohn's disease
- Gastrointestinal haemorrhage
- Perforation
- Melaena
- Haematemesis
- Gastrointestinal bleeding
Hepatobiliary Disorders
- Hepatitis
- Increased serum transaminases
- Elevated serum bilirubin
- Abnormal liver function
- Jaundice
Genitourinary Disorders
- Renal failure
- Tubulointerstitial nephritis
- Nephritic syndrome
Skin and Subcutaneous Tissue Disorders
- Pruritis
- Photosensitivity reactions
- Alopecia
- Urticaria
- Angioedema
- Bullous eruption
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
- Exfoliative and bullous dermatoses
- Purpura
Immune, Blood and and Lymphatic System Disorders
- Haemorrhagic anaemia
- Agranulocytosis
- Thrombocytopenia
- Bone marrow failure
- Neutropenia
- Anaphylactic reactions
Sensory Disorders
- Visual disturbances such as blurred vision
- Optic neuritis
- Tinnitus
Interactions
- Anticoagulants
- Platelet aggregation inhibitors
- Methotrexate
- Lithium
- Non-steroidal anti-inflammatory drugs
- Mifepristone
- Pentoxifylline
- Diuretics
- Cardiac glycosides
- Ciclosporin
- Corticosteroids
- Quinolone antibiotics
- Tacrolimus
- Thrombolytic agents
- Probenecid
- Selective serotonin reuptake inhibitors
- Angiotensin-converting enzyme inhibitors
- Angiotensin II blockers
- Zidovudine
Monitoring
None routine. Specific cases may require
- Renal function
- Hepatic function
Mechanism of action
Inhibits prostaglandin synthesis by inhibition of cyclooxygenase.
Dosage forms
- Capsule
Formulation
Capsule sr 200mg
- Ketoflam (Adcock) originator
Also available in the following form: Gel.
References
1. SAMF_12th Edition_Page 400 2. https://www.medicines.org.uk/emc/medicine/25503 21 October 2013_ SANOFI 3. http://home.intekom.com/pharm/adcock/ketoflam.html January 1996_SR 4. https://www.drugs.com/dosage/ketoprofen.html 5. https://drive.google.com/drive/folders/0B0xnChtF7vduZGtHeHgwd1Flb0k (10/01/1996_Ketoflam_200mg tab)
Brands & products
4 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldJutGeneric· 1 product
from R2.96/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Fastum dispenser pack | - g | 100 | S1 | R296.04 | R2.96 | R106.65 | 707853001 |
gelGeneric· 2 products
from R2.96/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Fastum gel | - g/100g | 100 | S1 | R296.04 | R2.96 | R106.65 | 799351016 |
| Fastum gel | - g/100g | 50 | S1 | R162.94 | R3.26 | R68.26 | 799351008 |
capsuleGeneric· 1 product
from R9.13/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Ketoflam | 200 mg | 30 | S3 | R274.01 | R9.13 | R100.59 | 822205009 |
- Ketoflam
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.